- Home
- ZOOZ vs CLDI Comparison
ZOOZ vs CLDI Comparison
Compare ZOOZ & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZOOZ
- CLDI
- Stock Information
- Founded
- ZOOZ 2013
- CLDI 2014
- Country
- ZOOZ Israel
- CLDI United States
- Employees
- ZOOZ N/A
- CLDI N/A
- Industry
- ZOOZ
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZOOZ
- CLDI Health Care
- Exchange
- ZOOZ NYSE
- CLDI Nasdaq
- Market Cap
- ZOOZ 8.8M
- CLDI 10.2M
- IPO Year
- ZOOZ N/A
- CLDI N/A
- Fundamental
- Price
- ZOOZ $1.09
- CLDI $0.57
- Analyst Decision
- ZOOZ Strong Buy
- CLDI
- Analyst Count
- ZOOZ 2
- CLDI 0
- Target Price
- ZOOZ $5.00
- CLDI N/A
- AVG Volume (30 Days)
- ZOOZ 69.8K
- CLDI 41.9M
- Earning Date
- ZOOZ 08-11-2025
- CLDI 08-12-2025
- Dividend Yield
- ZOOZ N/A
- CLDI N/A
- EPS Growth
- ZOOZ N/A
- CLDI N/A
- EPS
- ZOOZ N/A
- CLDI N/A
- Revenue
- ZOOZ $1,041,000.00
- CLDI N/A
- Revenue This Year
- ZOOZ $32.28
- CLDI N/A
- Revenue Next Year
- ZOOZ $192.59
- CLDI N/A
- P/E Ratio
- ZOOZ N/A
- CLDI N/A
- Revenue Growth
- ZOOZ 36.26
- CLDI N/A
- 52 Week Low
- ZOOZ $0.73
- CLDI $0.20
- 52 Week High
- ZOOZ $3.07
- CLDI $3.89
- Technical
- Relative Strength Index (RSI)
- ZOOZ N/A
- CLDI 57.42
- Support Level
- ZOOZ N/A
- CLDI $0.23
- Resistance Level
- ZOOZ N/A
- CLDI $1.60
- Average True Range (ATR)
- ZOOZ 0.00
- CLDI 0.16
- MACD
- ZOOZ 0.00
- CLDI 0.05
- Stochastic Oscillator
- ZOOZ 0.00
- CLDI 26.62
About ZOOZ ZOOZ POWER LTD
Zooz Power Ltd is a provider of Flywheel-based Power Boosting solutions enabling widespread deployment of ultra-fast charging infrastructure for electric vehicles (EV) while overcoming existing grid limitations. ZOOZ pioneers its flywheel-based power boosting technology, enabling efficient utilization and power management of a power-limited grid at an EV charging site. Its Flywheel technology allows high-performance, reliable, and cost-effective ultra-fast charging infrastructure. ZOOZ Power's sustainable, power-boosting solutions are built with longevity and the environment in mind, helping its customers and partners accelerate the deployment of fast-charging infrastructure, thus facilitating improved utilization rates, efficiency and greater flexibility.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.